TY - JOUR
T1 - Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer
AU - Hamada, Tsuyoshi
AU - Isayama, Hiroyuki
AU - Nakai, Yousuke
AU - Togawa, Osamu
AU - Kogure, Hirofumi
AU - Kawakubo, Kazumichi
AU - Tsujino, Takeshi
AU - Sasahira, Naoki
AU - Hirano, Kenji
AU - Yamamoto, Natsuyo
AU - Arizumi, Toshihiko
AU - Ito, Yukiko
AU - Matsubara, Saburo
AU - Sasaki, Takashi
AU - Yagioka, Hiroshi
AU - Yashima, Yoko
AU - Mohri, Dai
AU - Miyabayashi, Kohji
AU - Mizuno, Suguru
AU - Nagano, Rie
AU - Takahara, Naminatsu
AU - Toda, Nobuo
AU - Tada, Minoru
AU - Omata, Masao
AU - Koike, Kazuhiko
PY - 2011/9
Y1 - 2011/9
N2 - Background: Although the placement of self-expandable metal stents (SEMSs) has been widely accepted as palliation for distal malignant biliary obstruction, the risk factors for their early dysfunction remain unclear. Objective: To identify risk factors for early (<3 months) SEMS dysfunction in unresectable pancreatic cancer. Design: A multicenter retrospective study. Setting: Five tertiary referral centers. Patients: Patients were included who underwent first-time SEMS placement for distal malignant biliary obstruction caused by pancreatic cancer between April 1994 and August 2010. Main Outcome Measurements: Rates and causes of early dysfunction were evaluated, and risk factors were analyzed. Results: In all, 317 eligible patients were identified. Covered SEMSs were placed in 82% of patients. Duodenal invasion was observed endoscopically in 37%. The median time to dysfunction was 170 days. The rates of all and early SEMS dysfunction were 55% and 31%, respectively. The major causes of SEMS dysfunction were food impaction and nonocclusion cholangitis (21% each) in early dysfunction and sludge (29%) in nonearly dysfunction. The rate of early dysfunction was 42% with duodenal invasion and 24% without duodenal invasion (P =.001). Early dysfunction caused by food impaction was more frequent in patients with duodenal invasion (10% and 4%, P =.053). Duodenal invasion was a risk factor (odds ratio 2.35; 95% CI, 1.433.90; P =.001) in a multiple logistic regression model. Limitations: A retrospective design. Conclusions: Duodenal invasion is a risk factor for early SEMS dysfunction in patients with pancreatic cancer.
AB - Background: Although the placement of self-expandable metal stents (SEMSs) has been widely accepted as palliation for distal malignant biliary obstruction, the risk factors for their early dysfunction remain unclear. Objective: To identify risk factors for early (<3 months) SEMS dysfunction in unresectable pancreatic cancer. Design: A multicenter retrospective study. Setting: Five tertiary referral centers. Patients: Patients were included who underwent first-time SEMS placement for distal malignant biliary obstruction caused by pancreatic cancer between April 1994 and August 2010. Main Outcome Measurements: Rates and causes of early dysfunction were evaluated, and risk factors were analyzed. Results: In all, 317 eligible patients were identified. Covered SEMSs were placed in 82% of patients. Duodenal invasion was observed endoscopically in 37%. The median time to dysfunction was 170 days. The rates of all and early SEMS dysfunction were 55% and 31%, respectively. The major causes of SEMS dysfunction were food impaction and nonocclusion cholangitis (21% each) in early dysfunction and sludge (29%) in nonearly dysfunction. The rate of early dysfunction was 42% with duodenal invasion and 24% without duodenal invasion (P =.001). Early dysfunction caused by food impaction was more frequent in patients with duodenal invasion (10% and 4%, P =.053). Duodenal invasion was a risk factor (odds ratio 2.35; 95% CI, 1.433.90; P =.001) in a multiple logistic regression model. Limitations: A retrospective design. Conclusions: Duodenal invasion is a risk factor for early SEMS dysfunction in patients with pancreatic cancer.
UR - https://www.scopus.com/pages/publications/80052268470
U2 - 10.1016/j.gie.2011.04.046
DO - 10.1016/j.gie.2011.04.046
M3 - 記事
C2 - 21794859
AN - SCOPUS:80052268470
SN - 0016-5107
VL - 74
SP - 548
EP - 555
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 3
ER -